InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

- Current share price for PIQ : $0.155

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Application for quotation of securities - PIQ 6 Jun 2025 9:50AM $0.410 $0.155 fallen by 62.20%
$26 Application for quotation of securities - PIQ 6 Jun 2025 9:48AM $0.410 $0.155 fallen by 62.20%
$26 Update - Proposed issue of securities - PIQ 6 Jun 2025 8:19AM $0.410 $0.155 fallen by 62.20%
$26 Supplementary Prospectus 6 Jun 2025 8:19AM $0.410 $0.155 fallen by 62.20%
$26 A landmark in non-invasive Esophageal Cancer diagnosis 5 Jun 2025 9:22AM $0.395 $0.155 fallen by 60.76%
$26 $12 million capital raise completed with oversubscribed SPP 5 Jun 2025 8:49AM $0.395 $0.155 fallen by 60.76%
$26 Results of Meeting 30 May 2025 3:59PM $0.425 $0.155 fallen by 63.53%
$26 PromarkerEndo latest results presented at world congress 26 May 2025 8:21AM $0.420 $0.155 fallen by 63.10%
$26 Chinese patent granted for OxiDx technology 15 May 2025 9:13AM $0.360 $0.155 fallen by 56.94%
$26 Share Purchase Plan Offer Booklet 5 May 2025 10:24AM $0.380 $0.155 fallen by 59.21%
$26 Correction - Notice of Extraordinary General Meeting/Proxy 2 May 2025 1:53PM $0.380 $0.155 fallen by 59.21%
$26 Notice of Extraordinary General Meeting/Proxy Form 2 May 2025 9:34AM $0.380 $0.155 fallen by 59.21%
$26 Notice Under Section 708A 29 Apr 2025 10:13AM $0.380 $0.155 fallen by 59.21%
$26 Notification regarding unquoted securities - PIQ 29 Apr 2025 10:11AM $0.380 $0.155 fallen by 59.21%
$26 Application for quotation of securities - PIQ 29 Apr 2025 10:11AM $0.380 $0.155 fallen by 59.21%
$26 Options Prospectus 28 Apr 2025 5:20PM $0.380 $0.155 fallen by 59.21%
$26 Quarterly Activities/Appendix 4C Cash Flow Report 24 Apr 2025 8:23AM $0.390 $0.155 fallen by 60.26%
$26 Proposed issue of securities - PIQ 22 Apr 2025 11:07AM $0.445 $0.155 fallen by 65.17%
$26 Proposed issue of securities - PIQ 22 Apr 2025 11:07AM $0.445 $0.155 fallen by 65.17%
$26 Proposed issue of securities - PIQ 22 Apr 2025 11:07AM $0.445 $0.155 fallen by 65.17%
$26 Proposed issue of securities - PIQ 22 Apr 2025 11:07AM $0.445 $0.155 fallen by 65.17%
$26 $4.5m placement to launch Promarker diagnostics 22 Apr 2025 11:07AM $0.445 $0.155 fallen by 65.17%
$26 Trading Halt 16 Apr 2025 10:56AM $0.445 $0.155 fallen by 65.17%
$26 Pause in Trading 16 Apr 2025 10:46AM $0.445 $0.155 fallen by 65.17%
$26 Investor Presentation - JMM Biotech Forum 10 Apr 2025 9:00AM $0.450 $0.155 fallen by 65.56%

76 - 100 of 684 results

Page 4 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.